Ropes & Gray LLP > Shanghai, China > Firm Profile

Ropes & Gray LLP > The Legal 500 Rankings

China > Life sciences and healthcare: foreign firms Tier 1

Representing a number of global biopharmaceutical and medical device companies and consistently handling major deals in the Chinese healthcare and life sciences market, Ropes & Gray LLP deservedly retains its place at the apex of this market. Practice head and Asia regional managing partner Arthur Mok has a wealth of experience in the field and is particularly recommended for advice on acquisitions and commercial agreements in the immunology space. Regulatory, compliance and enforcement expert Katherine Wang and healthcare IP specialist Geoffrey Lin are also integral. Eric Wu, who has first-hand industry experience having worked in-house for Johnson & Johnson, is another name to note.

China > Investment funds: foreign firms Tier 3

Ropes & Gray LLP‘s asset management team remains a strong choice for US and global sovereign wealth funds and practice head Vincent Ip also counts institutional investors and fund sponsors among his clients. The team advises on a full range of investment transactions, as well as secondary transactions, such as GP-led fund recapitalisations. With a ‘wealth of market experience‘, Chune Loong Lum offers advice on the establishment and operation of private investment funds across China and Asia.

China > Private equity: foreign firms Tier 3

Ropes & Gray LLP service major players in the Chinese and Asia Pacific private equity market, spanning the likes of Ares, Bain Capital, ICBC and TPG. The diversity of mandates received is mirrored by the range of sector specialists the practice offers, with technology, consumer goods, financial services and real estate considered key areas of expertise. Oliver Nip leads the Hong Kong-based practice, highly active across the spectrum of transactions including minority investments, buyouts, joint ventures and co-investments. Boxin Wang was promoted to counsel in November 2022 and is highly sought after by Chinese, Hong Kong and multinational clients.

China > Regulatory/compliance: foreign firms Tier 3

Focusing on government and internal investigations, Ropes & Gray LLP is the go-to for life sciences, healthcare and pharmaceutical companies requiring regulatory and compliance assistance. The team also assists with cross-border and preventative mandates. In Hong Kong, practice head and enforcement specialist Andrew Dale is well-versed in representing global corporations in high-stakes corporate investigations, litigation, and arbitration. Working closely alongside Dale in Hong Kong is Geoffrey Atkins, who is active in civil and criminal anti-corruption and securities enforcement matters. Counsel Tina Yu provides on-the-ground presence, assisting in all litigation and enforcement matters from Shanghai.

China > Restructuring and insolvency: foreign firms Tier 3

China > Banking and finance: foreign firms Tier 4

Advising private equity sponsors on their financings across the Asia-Pacific region, Ropes & Gray LLP‘s core areas of expertise are leveraged and acquisition finance. The team also regularly works with Bain Capital on its finance deals in China, Japan and South Korea. Hong Kong-based Jackie Kahng is experienced in cross-border leveraged finance transactions, including acquisition and real estate financings, and Stephen Hui, who was promoted to counsel in November 2022, focuses on cross-border financing deals. Former restructuring partner Daniel Anderson  joined Freshfields Bruckhaus Deringer in May 2023.

China > Intellectual property: foreign firms Tier 4

Best known for its life sciences and tech sector-related IP credentials, Ropes & Gray LLP‘s team in Shanghai has a broad IP practice with a particular focus on transactional mandates. The experienced Geoffrey Lin has extensive experience handling domestic and cross-border IP matters.